Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Gastric polyps? 15 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Gastric polyps have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for HYDROCHLOROTHIAZIDE.

15
Reports of Gastric polyps with HYDROCHLOROTHIAZIDE
0.1%
of all HYDROCHLOROTHIAZIDE reports
0
Deaths
15
Hospitalizations

How Dangerous Is Gastric polyps From HYDROCHLOROTHIAZIDE?

Of the 15 reports, 15 (100.0%) required hospitalization.

Is Gastric polyps Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Fall (1,323) Malaise (1,312)

What Other Drugs Cause Gastric polyps?

ESOMEPRAZOLE (151) OMEPRAZOLE (144) OLMESARTAN MEDOXOMIL (135) ADALIMUMAB (97) HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL (87) PANTOPRAZOLE (78) LANSOPRAZOLE (55) RABEPRAZOLE (48) METHOTREXATE (46) RIVAROXABAN (33)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Gastric polyps Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Gastric polyps Reports All Drugs Causing Gastric polyps HYDROCHLOROTHIAZIDE Demographics